Integrating Fragment Screening and Covalent Chemistry to Drug DNA-Binding Proteins: RAD52 as a Case Study
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This work provides a chemical strategy for targeting DNA-binding proteins through DNA-mimetic fragment recognition, structure-guided preorganization, and covalent stabilization while delivering validated probes to interrogate RAD52 biology.
Appeared: Saturday, October 10. Journal of the American Chemical Society. Peer-reviewed journal.
DOI: 10.1021/jacs.6c16278